Cargando…
1639. A Review of Clinical Safety, Reactogenicity, and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine (mRNA-1010) in Adults
BACKGROUND: Seasonal influenza remains a public health threat with approximately 1 billion global infections annually. Vaccines based on messenger RNA (mRNA) technology are currently under investigation and have the potential to address limitations of current seasonal influenza vaccine platforms. He...
Autores principales: | Soens, Mieke, Kandinov, Boris, Ramirez-Schrempp, Daniela, Vakil, Jignesh, Pucci, Alicia, Huang, Wenmei, Guo, Jia, Du, Evelyn, Avanesov, Andrei, Rudden, Sinead, Hicks, Bryony, Livermore, Greg, Schaefers, Kristi, Lau, Mary, Nachbagauer, Raffael, Ananworanich, Jintanat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679053/ http://dx.doi.org/10.1093/ofid/ofad500.1473 |
Ejemplares similares
-
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis
por: Lee, Ivan T., et al.
Publicado: (2023) -
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022) -
Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023) -
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
por: Lee, Jisun, et al.
Publicado: (2023) -
Reactogenicity of mRNA- and Non-mRNA-Based COVID-19 Vaccines among Lactating Mother and Child Dyads
por: Jacob-Chow, Beth, et al.
Publicado: (2022)